StockData
Starling Oncology, Inc. logo

Starling Oncology, Inc. (STLN) bonds

STLNNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31Also trades as DFPH, STLNW
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 7/30
$3.40−0.14 (-3.95%)

Close on Nov 17, 2026Market cap $346.52MP/E –Yield –

Debt

Borrowings on the balance sheet, Sep 30, 2026

Total debt
$72.52M
Long-term debt
Net debt
$35.63M
After $36.90M of cash
Implied interest rate
13.22%
FY2025 interest ÷ average debt
Interest coverage
-3.2×
FY2025 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

When the debt comes due

Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2025

From the debt maturity table in the annual report (filing). “Later” is everything due after year five.

Notes and loans outstanding

As tagged in Starling Oncology's 10-Q for the period ended Jun 30, 2026

IssueCouponAmount issuedCarrying value
Facility Agreement
Convertible at $9 a share
4.00%$110.00M$85.89M

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

See a number that looks wrong?